Construction and Significance of Traditional Chinese Medicine Intervention Model in Patients with Ischemic Stroke in Communities

doi:10.12114/j.issn.1007-9572.2019.00.184

Abstract

Abstract: Background　At present，the community has achieved progress in exploring traditional Chinese medicine （TCM） intervention for stroke patients，but the process of TCM intervention is lack of scientific，standardized and authoritative evidence-based support.And the community lacks a reference process on how to establish TCM intervention model.Objective　To construct a patient-centered secondary TCM prevention model for ischemic stroke，and lay the foundation for the secondary prevention and management of ischemic stroke in the community.Methods　A retrospective study was conducted to summarize current researches on secondary prevention of stroke in China and abroad from CNKI，Wanfang Data Knowledge Service Platform，Web of Science，PubMed Database in August，2018.Expert consultation was carried out in September 2018，and the collection of secondary prevention tools for ischemic stroke at home and abroad was evaluated and screened.Based on the results of expert consultation，the basic framework of TCM intervention model for secondary prevention of ischemic stroke was constructed in October，2018.Results　The Community TCM intervention model for patients with ischemic stroke mainly consisted of three steps.First，TCM health practitioners in communities conducted health education for patients with ischemic stroke，to raise awareness of secondary prevention in the community；second，community health practitioners conducted Essen risk assessment and TCM intervention，and referred suspected patients with recurrent stroke to the hospital；third，after confirming the diagnosis by imaging examination and treating in the general hospital，patients in stable recovery period were referred to the corresponding community health service center，and included in the high risk reservoir management of ischemic stroke recurrence.Conclusion　The establishment of community TCM intervention model in patients with ischemic stroke has formed a practical and feasible implementation scheme，which has realized the patient-centered and rational application of TCM intervention and improved the secondary prevention of ischemic stroke in communities.

Key words: Ischemic stroke, Secondary prevention, Recurrence, TCM therapy, Essen model, Flowcharts

摘要： 背景　目前社区在探索脑卒中患者的中医干预方面已取得诸多成效，但中医干预流程多缺乏科学性、规范性，也缺乏权威循证支撑，同时，社区对于如何建立中医干预模式缺乏可供借鉴的流程。目的　构建以患者为中心的缺血性脑卒中二级预防中医干预模式，为社区缺血性脑卒中二级预防管理工作奠定基础。方法　于2018年8月，检索中国知网、万方数据知识服务平台、Web of Science、PubMed数据库，对国内外缺血性脑卒中二级预防进行检索；于2018年9月，通过开展专家会议咨询，对国内外缺血性脑卒中二级预防工具集合进行评议，并进行筛选；基于专家咨询结果，于2018年10月，构建缺血性脑卒中二级预防中医干预模式基本框架。结果　缺血性脑卒中患者社区中医干预模式主要包括3个步骤。第一，通过社区中医医师对社区缺血性脑卒中患者进行健康宣教，提高社区缺血性脑卒中患者二级预防的意识；第二，由社区中医医师进行Essen风险评估和中医干预，并将疑似再卒中患者向上转诊；第三，通过综合医院的影像学检查进行确诊并进行治疗，治疗后稳定的恢复期患者转诊至相应社区卫生服务中心，并纳入缺血性脑卒中复发高危库管理。结论　缺血性脑卒中患者社区中医干预模式的建立，形成了切实可用的执行方案，实现了以患者为中心，中医干预技术的合理应用，完善了社区缺血性脑卒中二级预防工作。

关键词: 缺血性脑卒中, 二级预防, 复发, 中医疗法, Essen模型, 流程图

TAO Qiongying,TANG Wei. Construction and Significance of Traditional Chinese Medicine Intervention Model in Patients with Ischemic Stroke in Communities　[J]. Chinese General Practice, 2019, 22(20): 2488-2494. DOI: 10.12114/j.issn.1007-9572.2019.00.184.
陶琼英,汤伟. 缺血性脑卒中患者社区中医干预模式的构建与意义研究[J]. 中国全科医学, 2019, 22(20): 2488-2494. DOI: 10.12114/j.issn.1007-9572.2019.00.184.

References

［1］张冬月，韩薇.我国脑卒中流行现状及危险因素研究进展［J］．世界最新医学信息文摘，2018，18（80）：122-123．DOI：10.19613/j.cnki.1671-3141.2018.80.053.
ZHANG D Y，HAN W.Current situation of stroke prevalence and risk factors in China［J］．World Latest Medicine Information，2018，18（80）：122-123．DOI：10.19613/j.cnki.1671-3141.2018.80.053.
［2］王陇德，刘建民，杨弋，等．《中国脑卒中防治报告2017》概要［J］．中国脑血管病杂志，2018，15（11）：611-616，封3．DOI：10.3969/j.issn.1672-5921.2018.11.010.
WANG L D，LIU J M，YANG Y，et al．Report on stroke prevention and treatment in China 2017：a summary［J］．Chinese Journal of Cerebrovascular Diseases，2018，15（11）：611-616，cover 3．DOI：10.3969 /j.issn.1672-5921.2018.11.010.
［3］严利南，曾广民，王艾，等．氨氯地平与贝那普利对高血压脑卒中二级预防的效果［J］．心脏杂志，2015，27（1）：34-37．DOI：10.13191/j.chj.2015.0009.
YAN L N，ZENG G M，WANG A，et al．Comparison of benazepril and amiodipine in secondary prevention of hypertensive stroke：prospective and randomized trial［J］．Chinese Heart Journal，2015，27（1）：34-37．DOI：10.13191/j.chj.2015.0009.
［4］武琳妍，郭智，段荣蓉.中医治疗缺血性脑卒中的研究现状［J］．医疗装备，2017，30（22）：196-197.
WU L Y，GUO Z，DUAN R R.Research status of traditional Chinese medicine in the treatment of ischemic stroke［J］．Medical Equipment，2017，30（22）：196-197.
［5］王力，张茁，何晓芬.541例复发缺血性脑卒中与短暂性脑缺血发作患者二级预防现状［J］．中国神经精神疾病杂志，2010，36（10）：594-597．DOI：10.3969/j.issn.1002-0152.2010.10.006.
WANG L，ZHANG Z，HE X F.Status of secondary prevention of 541 recurrent ischemic stroke or TIA patients［J］．Chinese Journal of Nervous and Mental Diseases，2010，36（10）：594-597．DOI：10.3969/j.issn.1002-0152.2010.10.006.
［6］陈斌.基层医护人员对脑卒中二级预防的认知现状［J］．内科，2015，10（3）：380-382．DOI：10.16121/j.cnki.cn45-1347/r.2015.03.41.
CHEN B.Cognitive status of primary health care workers on secondary prevention of stroke［J］．Internal Medicine of China，2015，10（3）：380-382．DOI：10.16121/j.cnki.cn45-1347/r.2015.03.41.
［7］中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组.中国缺血性脑卒中风险评估量表使用专家共识［J］．中华神经科杂志，2016，49（7）：519-525．DOI：10.3760/cma.j.issn.1006-7876.2016.07.003.
Chinese Society of Neurology，Chinese Stroke Society.Expert consensus on the use of ischemic stroke risk assessment scale in China［J］．Chinese Journal of Neurology，2016，49（7）：519-525．DOI：10.3760/cma.j.issn.1006-7876.2016.07.003.
［8］MESSé S R，GRONSETH G，KENT D M，et al．Practice advisory：recurrent stroke with patent foramen ovale （update of practice parameter）：report of the guideline development，dissemination，and implementation subcommittee of the American Academy of Neurology［J］．Neurology，2016，87（8）：815-821．DOI：10.1212/WNL.0000000000002961.
［9］CAMERON J I，O'CONNELL C，FOLEY N，et al．Canadian stroke best practice recommendations：managing transitions of care following stroke，guidelines update 2016［J］．Int J Stroke，2016，11（7）：807-822．DOI：10.1177/1747493016660102.
［10］JOHNSTON S C，ROTHWELL P M，NGUYEN-HUYNH M N，
et al．Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack［J］．Lancet，2007，369（9558）：283-292．DOI：10.1016/S0140-6736（07）60150-0.
［11］GILES M F，ROTHWELL P M.Systematic review and pooled analysis of published and unpublished validations of the ABCD and ABCD2 transient ischemic attack risk scores［J］．Stroke，2010，41（4）：667-673．DOI：10.1161/STROKEAHA.109.571174.
［12］GALVIN R，GERAGHTY C，MOTTERLINI N，et al．Prognostic value of the ABCD2 clinical prediction rule：a systematic review and meta-analysis［J］．Fam Pract，2011，28（4）：366-376．DOI：10.1093/fampra/cmr008.
［13］CANCELLI I，JANES F，GIGLI G L，et al．Incidence of transient ischemic attack and early stroke risk：validation of the ABCD2 score in an Italian population-based study［J］．Stroke，2011，42（10）：2751-2757．DOI：10.1161/STROKEAHA.110.612705.
［14］ROTHWELL P M，GILES M F，FLOSSMANN E，et al．A simple score（ABCD）to identify individuals at high early risk of stroke after transient ischaemic attack［J］．Lancet，2005，366（9479）：29-36．DOI：10.1016/S0140-6736（05）66702-5.
［15］CAPRIE Steering Committee.A randomised，blinded，trial of clopidogrel versus aspirin in patients at risk of ischaemic events（CAPRIE）．CAPRIE Steering Committee［J］．Lancet，1996，348（9038）：1329-1339.
［16］MENG X，WANG Y，ZHAO X，et al．Validation of the Essen Stroke Risk Score and the Stroke Prognosis Instrument Ⅱ in Chinese patients［J］．Stroke，2011，42（12）：3619-3620．DOI：10.1161/STROKEAHA.111.624148.
［17］THOMPSON D D，MURRAY G D，DENNIS M，et al．Formal and informal prediction of recurrent stroke and myocardial infarction after stroke：a systematic review and evaluation of clinical prediction models in a new cohort［J］．BMC Med，2014，12（1）：58．DOI：10.1186/1741-7015-12-58.
［18］KERNAN W N，HORWITZ R I，BRASS L M，et al．A prognostic system for transient ischemia or minor stroke［J］．Ann Intern Med，1991，114（7）：552-557.
［19］KERNAN W N，VISCOLI C M，BRASS L M，et al．The stroke prognosis instrumentⅡ（SPI-Ⅱ）：a clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke［J］．Stroke，2000，31（2）：456-462.
［20］刘敬霞，李建生.脑卒中社区二级预防和康复中医干预研究的意义［C］//第六次全国中西医结合养生学与康复医学学术研讨会论文集.中国中西医结合学会养生学与康复医学专业委员会第三届委员会换届大会暨第六次学术研讨会，北京，2009.
［21］党翠娇，蔡定芳，俞晓飞.缺血性脑卒中内科二级预防现状［J］．中西医结合心脑血管病杂志，2017，15（21）：2706-2709．DOI：10.3969/j.issn.1672-1349.2017.21.013.
DANG C J，CAI D F，YU X F.Current status of secondary prevention in internal medicine of ischemic stroke［J］．Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease，2017，15（21）：2706-2709．DOI：10.3969/j.issn.1672-1349.2017.21.013.
［22］关战立.中医辨证联合二级预防对脑卒中患者预后的影响［J］．光明中医，2016，31（24）：3543-3545．DOI：10.3969/j.issn.1003-8914.2016.24.003.
GUAN Z L.Effect of TCM syndrome differentiation and treatment combined with secondary prevention on the prognosis of stroke patients［J］．Guangming Journal of Chinese Medicine，2016，31（24）：3543-3545．DOI：10.3969/j.issn.1003-8914.2016.24.003.
［23］汪晗.穴位注射和中医理疗对脑卒中上肢功能障碍的作用［J］．光明中医，2018，33（15）：2238-2240．DOI：10.3969/j.issn.1003-8914.2018.15.042.
WANG H.The effect of acupoint injection and traditional Chinese medicine physiotherapy on motor dysfunction of upper limbs after stroke［J］．Guangming Journal of Chinese Medicine，2018，33（15）：2238-2240．DOI：10.3969/j.issn.1003-8914.2018.15.042.
［24］张小月，吕翠平，朱怡柯.护理干预结合中医治疗对脑卒中后抑郁症状及生活能力的影响［J］．光明中医，2017，32（16）：2410-2411．DOI：10.3969/j.issn.1003-8914.2017.16.054.
ZHANG X Y，LYU C P，ZHU Y K.Effect of nursing intervention combined with TCM therapy on post-stroke depression symptoms and life ability［J］．Guangming Journal of Chinese Medicine，2017，32（16）：2410-2411．DOI：10.3969/j.issn.1003-8914.2017.16.054.
［25］吴殷夏，姚瑜，王瑾.耳穴贴压加穴位贴敷对缺血性脑卒中二级预防的临床观察［J］．上海针灸杂志，2013，32（10）：811-813．DOI：10.3969/j.issn.1005-0957.2013.10.811.
WU Y X，YAO Y，WANG J.Clinical observations on auricular point plaster therapy plus acupoint application for the secondary prevention of ischemic stroke［J］．Shanghai Journal of Acupuncture and Moxibustion，2013，32（10）：811-813．DOI：10.3969/j.issn.1005-0957.2013.10.811.
［26］陈继根，吴吉霞，刘德红，等．社区脑卒中病人中医适宜技术利用的调查［J］．中国现代医生，2007，45（17）：106-108．DOI：10.3969/j.issn.1673-9701.2007.17.080.
CHEN J G，WU J X，LIU D H，et al．Investigation on the appropriate technology utilization of traditional Chinese medicine in community stroke patients［J］．China Modern Doctor，2007，45（17）：106-108．DOI：10.3969/j.issn.1673-9701.2007.17.080.
［27］张丹，张春红，马会靖，等．中医疗法预防脑卒中后抑郁有效性的系统评价［J］．中国中医急症，2017，26（4）：577-580．DOI：10.3969/j.issn.1004-745X.2017.04.004.
ZHANG D，ZHANG C H，MA H J，et al．A systematic review of the efficacy of Chinese therapy on preventing post-stroke depression［J］．Journal of Emergency in Traditional Chinese Medicine，2017，26（4）：577-580．DOI：10.3969/j.issn.1004-745X.2017.04.004.
［28］吉宏彬.中医“治未病”保健服务在缺血性脑卒中再卒中预防中的应用［J］．世界最新医学信息文摘，2017，17（75）：106-107．DOI：10.19613/j.cnki.1671-3141.2017.75.085.
JI H B.Application of “preventive treatment” health care service of traditional Chinese medicine in prevention of ischemic stroke［J］．World Latest Medicine Information，2017，17（75）：106-107．DOI：10.19613/j.cnki.1671-3141.2017.75.085.
［29］国务院.中医药发展战略规划纲要（2016—2030年）［EB/OL］．（2016-02-22）［2018-04-26］．http：//www.gov.cn/zhengce/content/2016-02/26/content_5046678.htm.
［30］上海市卫生和计划生育委员会，上海市中医药发展办公室.上海市中医药事业发展“十三五”规划［EB/OL］．（2017-04-27）［2018-04-26］．http://www.shanghai.gov.cn/nw2/nw2314/nw39309/nw39385/nw40603/u26aw52164.html.

[1]	ZHANG Juan, LI Haifen, LI Xiaoman, YAO Miao, MA Huizhen, MA Qiang. Construction of Recurrence Risk Prediction Model for Diabetic Foot Ulcer on the Basis of Logistic Regression, Support Vector Machine and BP Neural Network Model [J]. Chinese General Practice, 2023, 26(32): 4013-4019.
[2]	LIU Yue, LIU Qi, DONG Hui, LIU Yaling. Neuropsychological Changes of Cognitive Reverters after Stroke Based on the Montreal Cognitive Assessment (MoCA) with a Double Threshold [J]. Chinese General Practice, 2023, 26(27): 3417-3422.
[3]	WANG Xiaowen, XIAO Tongling, WANG Yi, YANG Ying, XIA Xiaoshuang, LI Xin. Relationship between Homocysteine Level and Acute Kidney Injury in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2023, 26(26): 3290-3296.
[4]	ZHA Qianqian, XU Lianying, CHEN Juan, HUANG Wen, ZHANG Xinqiong. Summary of Best Evidence for Prevention of Recurrence of Late-life Depression [J]. Chinese General Practice, 2023, 26(19): 2332-2338.
[5]	WANG Xin, ZHAO Ruibin, YANG Huafang, LIU Chong, LIU Tian, LU Cui, CHEN Didi. Phenotypic Characteristics and Recurrence Factors of MOG-IgG Associated Disorders in Children [J]. Chinese General Practice, 2023, 26(18): 2244-2249.
[6]	ZHANG Lulu, CHEN Huan, LUO Huan, CHEN Tingting, CHEN Xinyu, GAO Jing. Fear of Cancer Recurrence Assessment Tools Based on COSMIN: a Systematic Review [J]. Chinese General Practice, 2023, 26(17): 2138-2146.
[7]	SHEN Huiwen, LIN Yongzhong, CHEN Shuliang, ZHANG Lihong, MA Chunye, MA Deyuan, ZHANG Ce. Precise Thrombolytic Treatment for Stroke Using AI-based Algorithms: a Real-world Study [J]. Chinese General Practice, 2023, 26(17): 2070-2077,2088.
[8]	WANG Gang, YUE Rensong, GONG Guangming. A Case-control Study of Risk Factors for Recurrence of Diabetic Foot Ulcer after Complete Healing [J]. Chinese General Practice, 2023, 26(15): 1857-1862.
[9]	YAO Huihui, SHU Lin, YAO Linli, LI Sha, YANG Xiaotong, LI Yunchun. Sex-specific Analysis of Influencing Factors for the Association between Baseline Serum Uric Acid and Two-year Outcome after First Acute Ischemic Stroke [J]. Chinese General Practice, 2023, 26(05): 557-562.
[10]	LIU Fengdong, ZHANG Boqiang, YAN Han, JING Li, YU Xiaochen, WANG Li, LIU Yunfei, XING Liying, TIAN Yuanmeng. Prevalence and Influenceing Factors of Diabetes in Ichemic Stroke Patients [J]. Chinese General Practice, 2023, 26(02): 175-183.
[11]	SHAO Wei, HUANG Mengmeng, HE Dandan, HUANG Fuxin, NIU Hongyue. Influencing Factors of Severity of Functional Dyspepsia after Ischemic Stroke [J]. Chinese General Practice, 2022, 25(36): 4509-4514.
[12]	ZENG Zhigang, ZHENG Shimin, CHEN Xiaofen, MA Juan. Therapeutic Effect of Huazhi Suppository Combined with Cap-assisted Endoscopic Sclerotherapy on Internal Hemorrhoids [J]. Chinese General Practice, 2022, 25(35): 4412-4417.
[13]	LU Chunjian, LIU Wei, LIN Shaoxia, ZHU Yanxian, PI Min. Efficacy and Safety of the Five Commonly Used External Therapies of TCM Combined with Conventional Western Medicine in Treating Diabetic Peripheral Neuropathy: a Bayesian Network Meta-analysis [J]. Chinese General Practice, 2022, 25(33): 4106-4116.
[14]	Xiaoyue SUN, Fengling WANG, Aihua WANG. Research Progress on the Pathogenesis and Preventive Treatment of Ischemic Stroke in Breast Cancer-related Ischemic Stroke [J]. Chinese General Practice, 2022, 25(29): 3710-3714.
[15]	Xiaoyi LIU, Baoai WANG. Progress in Clinical Diagnosis and Treatment of Wake-up Stroke [J]. Chinese General Practice, 2022, 25(29): 3607-3615.